Top Suppliers:I want be here
Related CAS#:
117830-79-2 117137-85-6
72994-53-7 130918-91-1
80295-53-0 80295-56-3
80295-59-6 352020-03-2
1927910-48-2 83930-13-6
922014-37-7 922014-43-5
922014-46-8 922066-83-9
921926-95-6 922014-49-1
922014-52-6 921926-99-0
922120-52-3 922014-55-9

117830-79-2

117830-79-2 structure
117830-79-2 structure
  • Name: Enterostatin human
  • Chemical Name: (2S)-2-[[(2S)-1-[2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid
  • CAS Number: 117830-79-2
  • Molecular Formula: C21H36N8O6
  • Molecular Weight: 496.56100
  • Catalog: Peptides
  • Create Date: 2018-07-18 16:16:12
  • Modify Date: 2025-08-25 20:44:12
  • Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
Name (2S)-2-[[(2S)-1-[2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid
Synonyms CLAP
H-Ala-Pro-Gly-Pro-Arg-OH
Enterostatin human
APGPR
APGPR Enterostatin
Ala-pro-gly-pro-arg
Procolipase activation peptide
ALA-PRO-GLY-PRO-ARG
Enterostatin, human, mouse, rat
Description Enterostatin, human, mouse, rat is a pentapeptide that reduces fat intake.
Related Catalog
Target

Human Endogenous Metabolite

In Vitro In the perfused ratpancreas, Enterostatin, at 100 mM, inhibits the insulin response to 9 mM glucose (by 70%), 0.1 mM tolbutamide (by 40%), and 5 mM arginine (by 70%)[1].
In Vivo Chronically, enterostatin reduces fat intake, bodyweight, and body fat. This response may involve multiple metabolic effects of enterostatin, which include a reduction of insulin secretion, an increase in sympathetic drive to brown adipose tissue, and the stimulation of adrenal corticosteroid secretion[2]. Enterostatin enhances memory consolidation after central or oral administration at a dose of 10 nmol/mouse or 300 mg/kg, respectively, in a step-through type passive avoidance test in mice[3]. A dose of 38 nmol of enterostatin gives a significant inhibition of high-fat food intake, while at a higher dose of 76 nmol the inhibiting effect is lost. During the first hour, after injection of enterostatin, there is even a slight increase in food intake[4].
References

[1]. Silvestre RA, et al. Effect of enterostatin on insulin, glucagon, and somatostatin secretion in the perfused rat pancreas. Diabetes. 1996 Sep;45(9):1157-60.

[2]. Erlanson-Albertsson C, et al. Enterostatin--a peptide regulating fat intake. Obes Res. 1997 Jul;5(4):360-72.

[3]. Ohinata K, et al. Enterostatin (APGPR) enhances memory consolidation in mice. Peptides. 2007 Mar;28(3):719-21.

[4]. Sörhede M, et al. Enterostatin: a gut-brain peptide regulating fat intake in rat. J Physiol Paris. 1993;87(4):273-5.
Density 1.54g/cm3
Molecular Formula C21H36N8O6
Molecular Weight 496.56100
Exact Mass 496.27600
PSA 224.04000
Index of Refraction 1.681
Storage condition -20°C
Hazard Codes Xi
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:117830-79-2 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 117830-79-2 | Chemsrc address: https://www.chemsrc.com/en/baike/1195178.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved